Rodman David Malcom sold MLYS
March 9, 2026 · Form 4 insider transaction
Rodman David Malcom sold 2,171 shares of Mineralys Therapeutics, Inc. at $26.84 per share, a transaction worth $58.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,171
Price
$26.84
Total value
$58.3K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 9, 2026
Filing dateMarch 10, 2026
Shares owned after82,489
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.